COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 87 filers reported holding COGENT BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $252 | +10.5% | 29,902 | -11.8% | 0.00% | – |
| Q1 2024 | $228 | +88.4% | 33,921 | +65.0% | 0.00% | – |
| Q4 2023 | $121 | -62.3% | 20,561 | -37.6% | 0.00% | – |
| Q3 2023 | $321 | +22.1% | 32,954 | +48.5% | 0.00% | – |
| Q2 2023 | $263 | -22.9% | 22,184 | -29.9% | 0.00% | – |
| Q1 2023 | $341 | -36.0% | 31,639 | -31.3% | 0.00% | -100.0% |
| Q4 2022 | $533 | -99.9% | 46,065 | +9.4% | 0.00% | 0.0% |
| Q3 2022 | $628,000 | +173.0% | 42,122 | +65.5% | 0.00% | – |
| Q2 2022 | $230,000 | +20.4% | 25,455 | -0.4% | 0.00% | – |
| Q1 2022 | $191,000 | -12.8% | 25,545 | +0.2% | 0.00% | – |
| Q4 2021 | $219,000 | +1.9% | 25,506 | -0.3% | 0.00% | – |
| Q3 2021 | $215,000 | -16.7% | 25,585 | -19.5% | 0.00% | – |
| Q2 2021 | $258,000 | – | 31,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,884,977 | $52,708,902 | 10.29% |
| COMMODORE CAPITAL LP | 4,772,421 | $51,494,423 | 7.84% |
| TCG Crossover Management, LLC | 3,631,042 | $39,178,943 | 7.64% |
| Fairmount Funds Management LLC | 2,758,975 | $29,769,340 | 5.12% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,411,509 | 4.47% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 579,264 | $6,250,259 | 2.58% |
| 5AM Venture Management, LLC | 790,440 | $8,528,848 | 2.18% |
| Ghost Tree Capital, LLC | 550,000 | $5,935,000 | 1.75% |
| Frazier Life Sciences Management, L.P. | 2,159,154 | $23,297,272 | 1.69% |
| HighVista Strategies LLC | 183,984 | $1,985,187 | 1.62% |